Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

The Development and Validation of Updated Palliative and End-of-Life Care Competencies for Medical Undergraduates in Canada.

Bush SH, Roze des Ordons A, Chary S, Boyle AB.

J Palliat Med. 2019 Sep 5. doi: 10.1089/jpm.2019.0160. [Epub ahead of print]

PMID:
31486699
2.

Delirium: non-pharmacological and pharmacological management.

Boland JW, Lawlor PG, Bush SH.

BMJ Support Palliat Care. 2019 Jul 30. pii: bmjspcare-2019-001966. doi: 10.1136/bmjspcare-2019-001966. [Epub ahead of print] No abstract available.

PMID:
31366592
3.

Rating Delirium Severity Using the Nursing Delirium Screening Scale: A Validation Study in Patients in Palliative Care.

Barnes CJ, Webber C, Bush SH, McNamara-Kilian M, Brodeur J, Marchington K, Sabri E, Lawlor PG.

J Pain Symptom Manage. 2019 Jul 5. pii: S0885-3924(19)30371-9. doi: 10.1016/j.jpainsymman.2019.06.027. [Epub ahead of print] No abstract available.

PMID:
31283968
4.

Inclusion, characteristics and outcomes of people requiring palliative care in studies of non-pharmacological interventions for delirium: A systematic review.

Hosie A, Siddiqi N, Featherstone I, Johnson M, Lawlor PG, Bush SH, Amgarth-Duff I, Edwards L, Cheah SL, Phillips J, Agar M.

Palliat Med. 2019 Sep;33(8):878-899. doi: 10.1177/0269216319853487. Epub 2019 Jun 28.

5.

Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 years.

Matsuo K, Ross MS, Yunokawa M, Johnson MS, Machida H, Omatsu K, Klobocista MM, Im DD, Satoh S, Baba T, Ikeda Y, Bush SH, Hasegawa K, Blake EA, Takekuma M, Shida M, Nishimura M, Adachi S, Pejovic T, Takeuchi S, Yokoyama T, Ueda Y, Iwasaki K, Miyake TM, Yanai S, Nagano T, Takano T, Shahzad MM, Ueland FR, Kelley JL, Roman LD.

Surg Oncol. 2019 Jun;29:25-32. doi: 10.1016/j.suronc.2019.02.002. Epub 2019 Feb 7.

PMID:
31196490
6.

The incidence and prevalence of delirium across palliative care settings: A systematic review.

Watt CL, Momoli F, Ansari MT, Sikora L, Bush SH, Hosie A, Kabir M, Rosenberg E, Kanji S, Lawlor PG.

Palliat Med. 2019 Sep;33(8):865-877. doi: 10.1177/0269216319854944. Epub 2019 Jun 11.

PMID:
31184538
7.

Management of Diabetes Mellitus in Adults at the End of Life: A Review of Recent Literature and Guidelines.

Sharma A, Sikora L, Bush SH.

J Palliat Med. 2019 Sep;22(9):1133-1138. doi: 10.1089/jpm.2018.0614. Epub 2019 Mar 20.

PMID:
30892135
8.

Delirium management by palliative medicine specialists: a survey from the association for palliative medicine of Great Britain and Ireland.

Boland JW, Kabir M, Bush SH, Spiller JA, Johnson MJ, Agar M, Lawlor P.

BMJ Support Palliat Care. 2019 Mar 4. pii: bmjspcare-2018-001586. doi: 10.1136/bmjspcare-2018-001586. [Epub ahead of print]

PMID:
30837278
9.

Multicomponent non-pharmacological intervention to prevent delirium for hospitalised people with advanced cancer: study protocol for a phase II cluster randomised controlled trial.

Hosie A, Phillips J, Lam L, Kochovska S, Noble B, Brassil M, Kurrle SE, Cumming A, Caplan GA, Chye R, Le B, Ely EW, Lawlor PG, Bush SH, Davis JM, Lovell M, Brown L, Fazekas B, Cheah SL, Edwards L, Agar M.

BMJ Open. 2019 Jan 28;9(1):e026177. doi: 10.1136/bmjopen-2018-026177.

10.

A Scoping Review to Map Empirical Evidence Regarding Key Domains and Questions in the Clinical Pathway of Delirium in Palliative Care.

Lawlor PG, Rutkowski NA, MacDonald AR, Ansari MT, Sikora L, Momoli F, Kanji S, Wright DK, Rosenberg E, Hosie A, Pereira JL, Meagher D, Rice J, Scott J, Bush SH.

J Pain Symptom Manage. 2019 Mar;57(3):661-681.e12. doi: 10.1016/j.jpainsymman.2018.12.002. Epub 2018 Dec 12.

11.

Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element.

Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.

Surg Oncol. 2018 Sep;27(3):433-440. doi: 10.1016/j.suronc.2018.05.017. Epub 2018 May 11.

PMID:
30217299
12.

Clinical utility of CA-125 in the management of uterine carcinosarcoma.

Matsuo K, Ross MS, Yunokawa M, Johnson MS, Machida H, Omatsu K, Klobocista MM, Im DD, Satoh S, Baba T, Ikeda Y, Bush SH, Hasegawa K, Blake EA, Takekuma M, Shida M, Nishimura M, Adachi S, Pejovic T, Takeuchi S, Yokoyama T, Ueda Y, Iwasaki K, Miyake TM, Yanai S, Nagano T, Takano T, Shahzad MM, Ueland FR, Kelley JL, Roman LD.

J Gynecol Oncol. 2018 Nov;29(6):e88. doi: 10.3802/jgo.2018.29.e88. No abstract available.

13.

Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma.

Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Enomoto T, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.

Ann Surg Oncol. 2018 Nov;25(12):3676-3684. doi: 10.1245/s10434-018-6695-z. Epub 2018 Aug 13.

PMID:
30105438
14.

Delirium in adult cancer patients: ESMO Clinical Practice Guidelines.

Bush SH, Lawlor PG, Ryan K, Centeno C, Lucchesi M, Kanji S, Siddiqi N, Morandi A, Davis DHJ, Laurent M, Schofield N, Barallat E, Ripamonti CI; ESMO Guidelines Committee.

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv143-iv165. doi: 10.1093/annonc/mdy147. No abstract available.

PMID:
29992308
15.

Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.

Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Enomoto T, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.

Ann Surg Oncol. 2018 Sep;25(9):2756-2766. doi: 10.1245/s10434-018-6547-x. Epub 2018 Jul 3.

PMID:
29971677
16.

Significance of venous thromboembolism in women with uterine carcinosarcoma.

Matsuo K, Ross MS, Im DD, Klobocista MM, Bush SH, Johnson MS, Takano T, Blake EA, Ikeda Y, Nishimura M, Ueda Y, Shida M, Hasegawa K, Baba T, Adachi S, Yokoyama T, Satoh S, Machida H, Yanai S, Iwasaki K, Miyake TM, Takeuchi S, Takekuma M, Nagano T, Yunokawa M, Pejovic T, Omatsu K, Shahzad MMK, Kelley JL, Ueland FR, Roman LD.

Gynecol Oncol. 2018 Feb;148(2):267-274. doi: 10.1016/j.ygyno.2017.11.036. Epub 2017 Dec 13.

PMID:
29248197
17.

Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcoma.

Matsuo K, Ross MS, Yunokawa M, Johnson MS, Machida H, Omatsu K, Klobocista MM, Im DD, Satoh S, Baba T, Ikeda Y, Bush SH, Hasegawa K, Blake EA, Takekuma M, Shida M, Nishimura M, Adachi S, Pejovic T, Takeuchi S, Yokoyama T, Ueda Y, Iwasaki K, Miyake TM, Yanai S, Nagano T, Takano T, Shahzad MMK, Ueland FR, Kelley JL, Roman LD.

Gynecol Oncol. 2017 Dec;147(3):565-571. doi: 10.1016/j.ygyno.2017.10.008. Epub 2017 Oct 20.

PMID:
29056442
18.

Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery.

Matsuo K, Johnson MS, Im DD, Ross MS, Bush SH, Yunokawa M, Blake EA, Takano T, Klobocista MM, Hasegawa K, Ueda Y, Shida M, Baba T, Satoh S, Yokoyama T, Machida H, Ikeda Y, Adachi S, Miyake TM, Iwasaki K, Yanai S, Takeuchi S, Nishimura M, Nagano T, Takekuma M, Shahzad MMK, Pejovic T, Omatsu K, Kelley JL, Ueland FR, Roman LD.

J Surg Oncol. 2018 Mar;117(3):488-496. doi: 10.1002/jso.24861. Epub 2017 Oct 16.

PMID:
29044542
19.

Clinical Assessment and Management of Delirium in the Palliative Care Setting.

Bush SH, Tierney S, Lawlor PG.

Drugs. 2017 Oct;77(15):1623-1643. doi: 10.1007/s40265-017-0804-3. Review.

20.

Development of a French Version of the Edmonton Symptom Assessment System-Revised: A Pilot Study of Palliative Care Patients' Perspectives.

Nekolaichuk C, Huot A, Gratton V, Bush SH, Tarumi Y, Watanabe SM.

J Palliat Med. 2017 Sep;20(9):966-976. doi: 10.1089/jpm.2016.0510. Epub 2017 Apr 27.

PMID:
28448236
21.

Quality of clinical practice guidelines in delirium: a systematic appraisal.

Bush SH, Marchington KL, Agar M, Davis DH, Sikora L, Tsang TW.

BMJ Open. 2017 Mar 10;7(3):e013809. doi: 10.1136/bmjopen-2016-013809.

22.

Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma.

Matsuo K, Omatsu K, Ross MS, Johnson MS, Yunokawa M, Klobocista MM, Im DD, Bush SH, Ueda Y, Takano T, Blake EA, Hasegawa K, Baba T, Shida M, Satoh S, Yokoyama T, Machida H, Adachi S, Ikeda Y, Iwasaki K, Miyake TM, Yanai S, Nishimura M, Nagano T, Takekuma M, Takeuchi S, Pejovic T, Shahzad MM, Ueland FR, Kelley JL, Roman LD.

Gynecol Oncol. 2017 Apr;145(1):78-87. doi: 10.1016/j.ygyno.2017.02.001. Epub 2017 Feb 16.

PMID:
28215838
23.

Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma.

Matsuo K, Ross MS, Bush SH, Yunokawa M, Blake EA, Takano T, Ueda Y, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Takeuchi S, Nishimura M, Iwasaki K, Yanai S, Klobocista MM, Johnson MS, Machida H, Hasegawa K, Miyake TM, Nagano T, Pejovic T, Shahzad MM, Im DD, Omatsu K, Ueland FR, Kelley JL, Roman LD.

Gynecol Oncol. 2017 Feb;144(2):329-335. doi: 10.1016/j.ygyno.2016.11.042. Epub 2016 Dec 5.

PMID:
27931750
24.

I Don't Want to Die an Old Person.

Bush SH.

J Palliat Med. 2017 Apr;20(4):432. doi: 10.1089/jpm.2016.0474. Epub 2016 Nov 21. No abstract available.

PMID:
27870607
25.

The preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium: study protocol for a randomized controlled trial.

Bush SH, Lacaze-Masmonteil N, McNamara-Kilian MT, MacDonald AR, Tierney S, Momoli F, Agar M, Currow DC, Lawlor PG.

Trials. 2016 Aug 11;17:399. doi: 10.1186/s13063-016-1525-8.

26.

Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma.

Matsuo K, Takazawa Y, Ross MS, Elishaev E, Podzielinski I, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Matsuzaki S, Baba T, Satoh S, Shida M, Nishikawa T, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Fujiwara K, Hazama Y, Kadogami D, Moffitt MN, Takeuchi S, Nishimura M, Iwasaki K, Ushioda N, Johnson MS, Yoshida M, Hakam A, Li SW, Richmond AM, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Yamaguchi K, Oishi T, Kajiwara H, Hasegawa K, Yasuda M, Kawana K, Suda K, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Wakatsuki A, Sugiyama T, Pejovic T, Nagano T, Shimoya K, Andoh M, Shiki Y, Enomoto T, Sasaki T, Fujiwara K, Mikami M, Shimada M, Konishi I, Kimura T, Post MD, Shahzad MM, Im DD, Yoshida H, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.

Ann Oncol. 2016 Jul;27(7):1257-66. doi: 10.1093/annonc/mdw161. Epub 2016 Apr 6.

PMID:
27052653
27.

Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival.

Bush SH, Tollin S, Marchion DC, Xiong Y, Abbasi F, Ramirez IJ, Zgheib NB, Boac B, Judson PL, Chon HS, Wenham RM, Apte SM, Cubitt CL, Berglund AE, Havrilesky LJ, Lancaster JM.

Mol Clin Oncol. 2016 Mar;4(3):399-404. Epub 2016 Jan 7.

28.

Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer.

Bou Zgheib N, Marchion DC, Bush SH, Judson PL, Wenham RM, Apte SM, Lancaster JM, Gonzalez-Bosquet J.

Oncol Lett. 2016 Jan;11(1):323-329. Epub 2015 Nov 6.

29.

Therapeutic Dilemma: Prognostic Factors and Outcome for Neuroendocrine Tumors of the Cervix.

Abdallah R, Bush SH, Chon HS, Apte SM, Wenham RM, Shahzad MM.

Int J Gynecol Cancer. 2016 Mar;26(3):553-60. doi: 10.1097/IGC.0000000000000631.

PMID:
26825841
30.

Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance.

Boac BM, Xiong Y, Marchion DC, Abbasi F, Bush SH, Ramirez IJ, Khulpateea BR, Clair McClung E, Berry AL, Bou Zgheib N, Chon HS, Shahzad MM, Judson PL, Wenham RM, Apte SM, Berglund AE, Magliocco AM, Lancaster JM.

Gynecol Oncol. 2016 Feb;140(2):259-63. doi: 10.1016/j.ygyno.2015.12.026. Epub 2015 Dec 28.

31.

Robotic-Assisted Surgery in Gynecological Oncology.

Bush SH, Apte SM.

Cancer Control. 2015 Jul;22(3):307-13. Review.

PMID:
26351886
32.

The 80-hour work week for residents: views from obstetric and gynecology program directors.

Janoo J, Hashmi M, Seybold DJ, Shapiro R, Calhoun BC, Bush SH.

W V Med J. 2014 Sep-Oct;110(5):20-5.

33.

Delirium.

Bush SH, Lawlor PG.

CMAJ. 2015 Feb 3;187(2):129. doi: 10.1503/cmaj.141248. Epub 2014 Dec 8. No abstract available.

34.

Delirium in patients with cancer: assessment, impact, mechanisms and management.

Lawlor PG, Bush SH.

Nat Rev Clin Oncol. 2015 Feb;12(2):77-92. doi: 10.1038/nrclinonc.2014.147. Epub 2014 Sep 2. Review.

PMID:
25178632
35.

The Chinese herb polyphyllin D sensitizes ovarian cancer cells to cisplatin-induced growth arrest.

Al Sawah E, Marchion DC, Xiong Y, Ramirez IJ, Abbasi F, Boac BM, Bush SH, Bou Zgheib N, McClung EC, Khulpateea BR, Berry A, Hakam A, Wenham RM, Lancaster JM, Judson PL.

J Cancer Res Clin Oncol. 2015 Feb;141(2):237-42. doi: 10.1007/s00432-014-1797-x. Epub 2014 Aug 28.

PMID:
25164128
36.

Delirium diagnosis, screening and management.

Lawlor PG, Bush SH.

Curr Opin Support Palliat Care. 2014 Sep;8(3):286-95. doi: 10.1097/SPC.0000000000000062. Review.

37.

End-of-life delirium: issues regarding recognition, optimal management, and the role of sedation in the dying phase.

Bush SH, Leonard MM, Agar M, Spiller JA, Hosie A, Wright DK, Meagher DJ, Currow DC, Bruera E, Lawlor PG.

J Pain Symptom Manage. 2014 Aug;48(2):215-30. doi: 10.1016/j.jpainsymman.2014.05.009. Epub 2014 May 28. Review.

PMID:
24879997
38.

Practical assessment of delirium in palliative care.

Leonard MM, Nekolaichuk C, Meagher DJ, Barnes C, Gaudreau JD, Watanabe S, Agar M, Bush SH, Lawlor PG.

J Pain Symptom Manage. 2014 Aug;48(2):176-90. doi: 10.1016/j.jpainsymman.2013.10.024. Epub 2014 Apr 21. Review.

PMID:
24766745
39.

Clinical practice guidelines for delirium management: potential application in palliative care.

Bush SH, Bruera E, Lawlor PG, Kanji S, Davis DH, Agar M, Wright DK, Hartwick M, Currow DC, Gagnon B, Simon J, Pereira JL.

J Pain Symptom Manage. 2014 Aug;48(2):249-58. doi: 10.1016/j.jpainsymman.2013.09.023. Epub 2014 Apr 21. Review.

40.

Practice and documentation of palliative sedation: a quality improvement initiative.

McKinnon M, Azevedo C, Bush SH, Lawlor P, Pereira J.

Curr Oncol. 2014 Apr;21(2):100-3. doi: 10.3747/co.21.1773.

41.

An analytical framework for delirium research in palliative care settings: integrated epidemiologic, clinician-researcher, and knowledge user perspectives.

Lawlor PG, Davis DHJ, Ansari M, Hosie A, Kanji S, Momoli F, Bush SH, Watanabe S, Currow DC, Gagnon B, Agar M, Bruera E, Meagher DJ, de Rooij SEJA, Adamis D, Caraceni A, Marchington K, Stewart DJ.

J Pain Symptom Manage. 2014 Aug;48(2):159-175. doi: 10.1016/j.jpainsymman.2013.12.245. Epub 2014 Apr 12.

42.

The Richmond Agitation-Sedation Scale modified for palliative care inpatients (RASS-PAL): a pilot study exploring validity and feasibility in clinical practice.

Bush SH, Grassau PA, Yarmo MN, Zhang T, Zinkie SJ, Pereira JL.

BMC Palliat Care. 2014 Mar 31;13(1):17. doi: 10.1186/1472-684X-13-17.

43.

Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development.

Bush SH, Kanji S, Pereira JL, Davis DHJ, Currow DC, Meagher D, Rabheru K, Wright D, Bruera E, Hartwick M, Gagnon PR, Gagnon B, Breitbart W, Regnier L, Lawlor PG.

J Pain Symptom Manage. 2014 Aug;48(2):231-248. doi: 10.1016/j.jpainsymman.2013.07.018. Epub 2014 Jan 28. Review.

44.

Ethical challenges and solutions regarding delirium studies in palliative care.

Sweet L, Adamis D, Meagher DJ, Davis D, Currow DC, Bush SH, Barnes C, Hartwick M, Agar M, Simon J, Breitbart W, MacDonald N, Lawlor PG.

J Pain Symptom Manage. 2014 Aug;48(2):259-71. doi: 10.1016/j.jpainsymman.2013.07.017. Epub 2013 Dec 31. Review.

45.

Toward better care of delirious patients at the end of life: a pilot study of an interprofessional educational intervention.

Brajtman S, Wright D, Hall P, Bush SH, Bekele E.

J Interprof Care. 2012 Sep;26(5):422-5. doi: 10.3109/13561820.2012.694503. Epub 2012 Jun 18.

PMID:
22708995
46.

Robotic-assisted hysterectomy in a patient with a ventriculoperitoneal shunt.

Bush SH, Greg Heywood S, Calhoun BC.

J Robot Surg. 2011 Dec;5(4):291-3. doi: 10.1007/s11701-011-0264-9. Epub 2011 Mar 27.

PMID:
27628120
47.

Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: a preliminary study.

Elsayem A, Bush SH, Munsell MF, Curry E 3rd, Calderon BB, Paraskevopoulos T, Fadul N, Bruera E.

J Pain Symptom Manage. 2010 Nov;40(5):774-82. doi: 10.1016/j.jpainsymman.2010.02.017. Epub 2010 Aug 21.

PMID:
20728301
48.

Single- vs. multiple-item instruments in the assessment of quality of life in patients with advanced cancer.

Bush SH, Parsons HA, Palmer JL, Li Z, Chacko R, Bruera E.

J Pain Symptom Manage. 2010 Mar;39(3):564-71. doi: 10.1016/j.jpainsymman.2009.08.006.

PMID:
20303030
49.

Neuroleptic dose in the management of delirium in patients with advanced cancer.

Hui D, Bush SH, Gallo LE, Palmer JL, Yennurajalingam S, Bruera E.

J Pain Symptom Manage. 2010 Feb;39(2):186-96. doi: 10.1016/j.jpainsymman.2009.07.009.

PMID:
20152585
50.

The assessment and management of delirium in cancer patients.

Bush SH, Bruera E.

Oncologist. 2009 Oct;14(10):1039-49. doi: 10.1634/theoncologist.2009-0122. Epub 2009 Oct 6. Review.

Supplemental Content

Support Center